ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank44
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P44
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-3.18%
Q3 202514.66%
Q2 202515.62%
Q1 2025-5.46%
Q4 20245.03%
Q3 202422.06%
Q2 2024-10.73%
Q1 202421.75%
Q4 202310.82%
Q3 2023-49.27%
Q2 2023-13.17%
Q1 20231.71%
Q4 202213.05%
Q3 2022-7.29%
Q2 2022-34.19%
Q1 202213.73%
Q4 2021-15.76%
Q3 2021-50.95%
Q2 2021-14.73%
Q1 202124.44%
Q4 2020-84.40%
Q3 202010.15%
Q2 2020-107.76%
Q1 202029.75%
Q4 2019-155.06%
Q3 201927.47%
Q2 20190.97%
Q1 20190.00%